Dying blood mononuclear cell secretome exerts antimicrobial activity

European Journal of Clinical Investigation

Volumn 46, Issue 10, 2016, Pages 853-863

  Kasiri, Mohammad Mahdi ^a   Beer, Lucian ^a,b   Nemec, Lucas ^b   Gruber, Florian ^a,c   Pietkiewicz, Sabine ^d   Haider, Thomas ^a   Simader, Elisabeth Maria ^a   Traxler, Denise ^a   Schweiger, Thomas ^b   Janik, Stefan ^a   Taghavi, Shahrokh ^b   Gabriel, Christian ^e   Mildner, Michael ^c   Ankersmit, Hendrik Jan ^a,b  

^a INSTITUTE FOR MICROELECTRONICS   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e Red Cross Blood Transfusion Service of Upper Austria   (Austria)

Author keywords

Antimicrobial peptides; diabetic foot ulcer; MNC secretome; mononuclear cell; peripheral blood mononuclear cells

Indexed keywords

ADENOSINE PHOSPHATE; CATHELICIDIN; PEPTIDES AND PROTEINS; SECRETOME; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERICIDAL ACTIVITY; CELLULAR SECRETION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; EXPERIMENTAL SURGICAL WOUND; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MALE; MONONUCLEAR CELL; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; RADIATION EXPOSURE; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; WOUND HEALING;

EID: 84988934524     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12667     Document Type: Article

References (41)

1. Gudmundsson GH, Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 1999;232:45–54.
2. Niyonsaba F, Iwabuchi K, Someya A, Hirata M, Matsuda H, Ogawa H et al. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002;106:20–6.
3. da Costa JP, Cova M, Ferreira R, Vitorino R. Antimicrobial peptides: an alternative for innovative medicines? Appl Microbiol Biotechnol 2015;99:2023–40.
4. Reddy KV, Yedery RD, Aranha C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents 2004;24:536–47.
5. Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J, Cardenas A et al. Expression of antimicrobial peptides in diabetic foot ulcer. J Dermatol Sci 2012;65:19–26.
6. Vu BG, Stach CS, Salgado-Pabón W, Diekema DJ, Gardner SE, Schlievert PM. Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers. J Infect Dis 2014;210:1920–7.
7. Ho TK, Leigh RD, Tsui J. Diabetic foot disease and oedema. Br J Diabetes Vasc Dis 2012;13:45–50.
8. Waniczek D, Kozowicz A, Muc-Wierzgoń M, Kokot T, Świętochowska E, Nowakowska-Zajdel E. Adjunct methods of the standard diabetic foot ulceration therapy. Evid Based Complement Alternat Med 2013;12:243568.
9. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010;28:2229–38.
10. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648–59.
11. Ren G, Chen X, Dong F, Li W, Ren X, Zhang Y et al. Concise review: mesenchymal stem cells and translational medicine: emerging issues. Stem cells Transl Med 2012;1:51–8.
12. Maharlooeia MK, Bagheri M, Solhjoua Z, Jahromia BM, Akramib M, Rohanic L et al. Adipose tissue derived mesenchymal stem cell (AD-MSC) promotes skin wound healing in diabetic rats. Diabetes Res Clin Pract 2011;93:228–34.
13. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11:367–8.
14. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008;29:2851–8.
15. Ankersmit HJ, Hoetzenecker K, Dietl W, Soleiman A, Horvat R, Wolfsberger M et al. Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 2009;39:445–56.
16. Hoetzenecker K, Assinger A, Lichtenauer M, Mildner M, Schweiger T, Starlinger P et al. Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol 2012;107:292.
17. Hoetzenecker K, Zimmermann M, Hoetzenecker W, Schweiger T, Kollmann D, Mildner M et al. Mononuclear cell secretome protects from experimental autoimmune myocarditis. Eur Heart J 2013;36:676–85.
18. Altmann P, Mildner M, Haider T, Traxler D, Beer L, Ristl R et al. Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. F1000Res 2014;3:131.
19. Mildner M, Hacker S, Haider T, Gschwandtner M, Werba G, Barresi C et al. Secretome of peripheral blood mononuclear cells enhances wound healing. PLoS One 2013;8:e60103.
20. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086–93.
21. Hacker S, Mittermayr R, Mildner M, Haider T, Nickl S, Zimmermann M et al. Paracrine factors from irradiated peripheral blood mononuclear cells improve skin regeneration and angiogenesis in a porcine burn model. Sci Rep 2016;6:25168.
22. Beer B, Seemann R, Ristl R, Ellinger A, Kasiri MM, Mitterbauer A et al. High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells. BMC Genom 2014;15:814.
23. Sabine P, Schmidt JH, Lavrik IN. Quantification of apoptosis and necroptosis at the single cell level by a combination of imaging flow cytometry with classical annexin V/propidium iodide staining. J Immunol Methods 2015;423:99–103.
24. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
25. Mildner M, Stichenwirth M, Abtin A, Eckhart L, Sam C, Gläser R et al. Psoriasin (s100a7) is a major Escherichia coli-cidal factor of the female genital tract. Mucosal Immunol 2010;3:602–9.
26. Beer L, Zimmermann M, Mitterbauer A, Ellinger A, Gruber F, Narzt MS et al. Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep 2015;5:16662.
27. Krammer PH, Arnold R, Lavrik IN. Life and death in peripheral T cells. Nat Rev Immunol 2007;7:532–42.
28. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010;11:700–14.
29. Haider T, Höftberger R, Rüger B, Mildner M, Blumer R, Mitterbauer A et al. The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Exp Neurol 2015;S0014-4886:00081–3.
30. Edmonds M, Foster A. The use of antibiotics in the diabetic foot. Am J Surg 2004;187:25–8.
31. Yang M, Sheng L, Zhang TR, Li Q. Stem cell therapy for lower extremity diabetic ulcers: where do we stand? Biomed Res Int 2013;2013:462179.
32. Wukich DK, Hobizal KB, Brooks MM. Severity of diabetic foot infection and rate of limb salvage. Foot Ankle Int 2013;34:351–8.
33. Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003;361:1545–51.
34. Lichtenauer M, Mildner M, Hoetzenecker K, Zimmermann M, Podesser BK, Sipos W et al. Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol 2011;106:1283–97.
35. Urvish T, Parameswaran S, Armstrong A, Burgueno Vega D, Griswold J, Dissanaike S et al. Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds. J Pathog 2014;2014:173053.
36. Lowy F. Staphylococcus aureus infections. N Engl J Med 1998;339:520–32.
37. Spaulding AR, Salgado-Pabón W, Kohler PL, Horswill AR, Leung DY, Schlievert PM. Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev 2013;26:422–47.
38. Chertov O, Michiel DF, Xu L et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996;271:2935–40.
39. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525–8.
40. Welling MM, Hiemstra PS, van den Barselaar MT, Paulusma-Annema A, Nibbering PH, Pauwels EK et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Investig 1998;102:1583–90.
41. Salvado MD, Di Gennaro A, Lindbom L, Agerberth B, Haeggström JZ. Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin. Arterioscler Thromb Vasc Biol 2013;33:1965–72.